Skip to main content
Abnova logo

Abnova — Investor Relations & Filings

Ticker · 4133 ISIN · TW0004133004 TW Professional, scientific and technical activities
Filings indexed 1,483 across all filing types
Latest filing 2013-10-09 Financial Supplement Da…
Country TW Taiwan
Listing TW 4133

About Abnova

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
102年9月營業收入
Financial Supplement Data Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 亞諾法, with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document is very short (764 characters) and primarily presents financial summary data without detailed financial statements or analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It also does not announce a report publication or contain management commentary. Given the nature of the data and the short length, this fits best as a Financial Supplement Data (XLSX) type, which is supplementary financial data, although the format here is text, the content aligns with supplementary financial data rather than a full report or announcement. Confidence is high due to clear financial summary data and short length.
2013-10-09 Chinese
初次上市公司承諾事項後續執行情形(至102年第3季止)
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (亞諾法生技股份有限公司) regarding the follow-up on commitments made after its initial public listing. It details compliance with disclosure requirements, stock holding commitments by executives, and enhanced disclosure in financial reports. The document is short (1326 characters) and does not contain actual financial statements or detailed financial data. It is an update on regulatory compliance and company commitments rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-10-07 Chinese
102年8月營業收入
Regulatory Filings Classification · 90% confidence The document is a summarized revenue report from a listed company (亞諾法) showing monthly and cumulative net operating revenue figures for a specific month and year (民國102年08月, which corresponds to August 2013). It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting requirements. The document is very short (765 characters) and contains only financial summary data without detailed financial statements or management discussion. It does not appear to be a full annual or interim report, nor an earnings release with highlights. It is more of a regulatory or public disclosure of revenue figures. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS) rather than a full financial report or announcement of a report publication.
2013-09-09 Chinese
102年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (亞諾法) providing information about fund lending balances and endorsement guarantees for a specific month (August of the 102nd year in the ROC calendar, which corresponds to 2013). The content is tabular and concise, focusing on financial data related to capital loans and guarantees without detailed financial statements or narrative analysis. The document length is short (610 characters), and it does not contain comprehensive financial results or management discussion. It appears to be a regulatory disclosure of specific financial data rather than a full report or announcement of a report. Given the nature of the data and the format, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2013-09-09 Chinese
102年08月董事會成員及持股
Director's Dealing Classification · 100% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current and initial shareholdings, pledged shares, and related party holdings. It is focused on insider share ownership and changes, with no financial statements or earnings data. The document length is 3324 characters, which is relatively short and contains no indication of being a report or announcement of a report. The content matches the definition of a Director's Dealing report, which involves reporting personal share transactions or holdings by company directors and executives. Therefore, the appropriate classification is Director's Dealing (DIRS).
2013-09-06 Chinese
102年08月內部人持股異動(事後)
Major Shareholding Notification Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider shareholding disclosures rather than financial results, management changes, or meeting materials. There is no indication of financial statements, earnings data, or meeting presentations. The document is a regulatory disclosure of insider shareholdings, which aligns with the category of Major Shareholding Notification (MRQ). The document length is substantial and contains actual data on shareholdings, not just an announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the best classification is MRQ.
2013-09-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.